Valiant Laboratories (MAIN BOARD)
September 27, 2023 – October 3, 2023
| Price | ₹133 - ₹140 |
| Premium | ₹20 |
|---|---|
| Lot size | 105 |
| Allotment | Oct 4, 2023 |
| Listing | Oct 6, 2023 |
Live Rate
| Open | |
|---|---|
| High | |
| Low | |
| Prev. Close | |
| Lower circuit | |
| Upper circuit | |
| 52w High | |
| 52w Low | |
| P/E Ratio |
Valiant Laboratories (MAIN BOARD) Listing Price
| Exchange | Listing Price | Gain/Loss | % |
|---|---|---|---|
| NSE | ₹161.00 | +₹21.00 | +15.00% |
| BSE | ₹162.15 | +₹22.15 | +15.82% |
Valiant Laboratories (MAIN BOARD) Subscription
Last Updated as on 03-Oct-2023 17:57:00
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIBs | 21,78,030 | 4,53,61,155 | 20.83 |
| HNIs | 16,33,500 | 12,02,80,965 | 73.63 |
| HNIs (10+L) | 10,88,999 | 8,56,36,635 | 78.64 |
| HNIs (2-10L) | 5,44,501 | 3,46,44,330 | 63.63 |
| Retail | 38,11,500 | 6,11,70,900 | 16.05 |
| Total | 76,23,030 | 22,68,13,020 | 29.75 |
Valiant Laboratories (MAIN BOARD) About
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 105 | 14700 | 36300 |
| sHNI | 14 | 1470 | 205800 | 370 |
| bHNI | 69 | 7245 | 1014300 | 741 |
Incorporated in 1980, Valiant Laboratories Limited is an Active Pharmaceutical ingredient Manufacturing company in India having focus on manufacturing of Paracetamol.
The company's manufacturing unit is located in Palghar, Maharashtra, spread across 2,000 sq. mts. of land with an aggregate annual total installed capacity of 9,000 MT per annum. The company also has an R&D Facility, equipped with an analytical laboratory and infrastructure for developmental activities in existing products.
Valiant Laboratories IPO Details
| Issue Size | 11,556,000 shares (aggregating up to ₹[152] Cr) |
| Fresh Issue | 11,556,000 shares (aggregating up to ₹[152] Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 32,560,000 |
| Share holding post issue | 44,116,000 |
Valiant Laboratories IPO Reservation
| QIB Shares Offered | Not more than 50.00% of the Net offer |
| NII (HNI) Shares Offered | Not less than 15.00% of the Offer |
| Retail Shares Offered | Not less than 35.00% of the Offer |
Company Financials
| Period | Mar 2021 | Mar 2022 | Mar 2023 |
| Assets | 106.31 | 181.81 | 212.76 |
| Revenue | 183.78 | 293.47 | 338.77 |
| Profit | 30.59 | 27.50 | 29.00 |
| Net Worth | 88.58 | 71.46 | 100.49 |
| Reserves | |||
| Borrowing | 0.35 | 60.68 | 59.40 |
Strength
Weakness
Valiant Laboratories (MAIN BOARD) Latest Announcements
| Date | Subject | Attachment Text |
|---|
Valiant Laboratories (MAIN BOARD) Financial Results
Valiant Laboratories (MAIN BOARD) Lead Manager(s)
Valiant Laboratories (MAIN BOARD) Address
Valiant Laboratories Limited
104,Udyog Kshetra,
Mulund Goregaon Link Road,
Mulund West, Mumbai -400080
Phone: +91 2249712001
Email: complianceofficer@valiantlabs.in
Website: https://valiantlabs.in/
Valiant Laboratories (MAIN BOARD) Registrar
MUFG Intime India Private Limited (Link Intime)
Link Intime India Private Ltd
C 101, 247 Park,
L.B.S.Marg Vikhroli (West),
Mumbai - 400083